Brunei Darussalam vs Myanmar: Women's share of population ages 15+ living with HIV
Brunei Darussalam
41.8%
in 2024
Myanmar
41.5%
in 2024
Brunei Darussalam rank
67th
Myanmar rank
68th
Women's share of population ages 15+ living with HIV over time
- Brunei Darussalam
- Myanmar
How they compare
Brunei Darussalam currently reports 41.8% against 41.5% in Myanmar, a difference of 0.3%.
The two have swapped places 1 time across 19 shared years of data; in 2006 it was Myanmar ahead.
Brunei Darussalam ranks 67th and Myanmar ranks 68th of 172 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.8% | 38.1% | 16.3% | Myanmar |
| 2010s | 33.5% | 41.4% | 7.9% | Myanmar |
| 2020s | 41.2% | 41.8% | 0.6% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Brunei Darussalam or Myanmar?
- Brunei Darussalam, at 41.8% against 41.5% in Myanmar as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Brunei Darussalam and Myanmar?
- 0.3%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Myanmar?
- 19 years are reported by both, from 2006 to 2024.
- How do Brunei Darussalam and Myanmar rank globally for women's share of population ages 15+ living with hiv?
- Brunei Darussalam ranks 67th and Myanmar ranks 68th of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.